The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy

Henrieke A.B. Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J. Overmars, Grigorius Papageorgiou, Yvonne M. Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J.A. Rijnders, Hannelore I. Bax, Eric C.M. van Gorp, Jan L. Nouwen, Theodora E.M.S. de Vries-Sluijs, Carolina A.M. Schurink, Mariana de Mendonça Melo, Els van Nood, Angela ColbersDavid Burger, Robert Jan Palstra, Jeroen J.A. van Kampen, David A.M.C. van de Vijver, Thibault Mesplède, Peter D. Katsikis, Rob A. Gruters, Birgit C.P. Koch, Annelies Verbon, Tokameh Mahmoudi*, Casper Rokx

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)
79 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science